Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Vaccine Adjuvants Market, by Type
1.4.2 Global Vaccine Adjuvants Market, by Administration
1.4.3 Global Vaccine Adjuvants Market, by Application
1.4.4 Global Vaccine Adjuvants Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Oct) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Global Vaccine Adjuvants Market, by Type
5.1 Global Particulate Market, by Region
5.2 Global Adjuvant Emulsion Market, by Region
5.3 Global Pathogen Market, by Region
5.4 Global Combination Market, by Region
5.5 Global Others Market, by Region
Chapter 6. Global Vaccine Adjuvants Market, by Administration
6.1 Global Intramuscular Market, by Region
6.2 Global Intranasal Market, by Region
6.3 Global Oral Market, by Region
6.4 Global Intradermal Market, by Region
6.5 Global Others Market, by Region
Chapter 7. Global Vaccine Adjuvants Market, by Application
7.1 Global Infectious Diseases Market, by Region
7.2 Global Cancer Market, by Region
7.3 Global Others Market, by Region
Chapter 8. Global Vaccine Adjuvants Market, by Region
8.1 North America Vaccine Adjuvants Market
8.1.1 North America Vaccine Adjuvants Market, by Type
8.1.1.1 North America Particulate Market, by Country
8.1.1.2 North America Adjuvant Emulsion Market, by Country
8.1.1.3 North America Pathogen Market, by Country
8.1.1.4 North America Combination Market, by Country
8.1.1.5 North America Others Market, by Country
8.1.2 North America Vaccine Adjuvants Market, by Administration
8.1.2.1 North America Intramuscular Market, by Country
8.1.2.2 North America Intranasal Market, by Country
8.1.2.3 North America Oral Market, by Country
8.1.2.4 North America Intradermal Market, by Country
8.1.2.5 North America Others Market, by Country
8.1.3 North America Vaccine Adjuvants Market, by Application
8.1.3.1 North America Infectious Diseases Market, by Country
8.1.3.2 North America Cancer Market, by Country
8.1.3.3 North America Others Market, by Country
8.1.4 North America Vaccine Adjuvants Market, by Country
8.1.4.1 US Vaccine Adjuvants Market
8.1.4.1.1 US Vaccine Adjuvants Market, by Type
8.1.4.1.2 US Vaccine Adjuvants Market, by Administration
8.1.4.1.3 US Vaccine Adjuvants Market, by Application
8.1.4.2 Canada Vaccine Adjuvants Market
8.1.4.2.1 Canada Vaccine Adjuvants Market, by Type
8.1.4.2.2 Canada Vaccine Adjuvants Market, by Administration
8.1.4.2.3 Canada Vaccine Adjuvants Market, by Application
8.1.4.3 Mexico Vaccine Adjuvants Market
8.1.4.3.1 Mexico Vaccine Adjuvants Market, by Type
8.1.4.3.2 Mexico Vaccine Adjuvants Market, by Administration
8.1.4.3.3 Mexico Vaccine Adjuvants Market, by Application
8.1.4.4 Rest of North America Vaccine Adjuvants Market
8.1.4.4.1 Rest of North America Vaccine Adjuvants Market, by Type
8.1.4.4.2 Rest of North America Vaccine Adjuvants Market, by Administration
8.1.4.4.3 Rest of North America Vaccine Adjuvants Market, by Application
8.2 Europe Vaccine Adjuvants Market
8.2.1 Europe Vaccine Adjuvants Market, by Type
8.2.1.1 Europe Particulate Market, by Country
8.2.1.2 Europe Adjuvant Emulsion Market, by Country
8.2.1.3 Europe Pathogen Market, by Country
8.2.1.4 Europe Combination Market, by Country
8.2.1.5 Europe Others Market, by Country
8.2.2 Europe Vaccine Adjuvants Market, by Administration
8.2.2.1 Europe Intramuscular Market, by Country
8.2.2.2 Europe Intranasal Market, by Country
8.2.2.3 Europe Oral Market, by Country
8.2.2.4 Europe Intradermal Market, by Country
8.2.2.5 Europe Others Market, by Country
8.2.3 Europe Vaccine Adjuvants Market, by Application
8.2.3.1 Europe Infectious Diseases Market, by Country
8.2.3.2 Europe Cancer Market, by Country
8.2.3.3 Europe Others Market, by Country
8.2.4 Europe Vaccine Adjuvants Market, by Country
8.2.4.1 Germany Vaccine Adjuvants Market
8.2.4.1.1 Germany Vaccine Adjuvants Market, by Type
8.2.4.1.2 Germany Vaccine Adjuvants Market, by Administration
8.2.4.1.3 Germany Vaccine Adjuvants Market, by Application
8.2.4.2 UK Vaccine Adjuvants Market
8.2.4.2.1 UK Vaccine Adjuvants Market, by Type
8.2.4.2.2 UK Vaccine Adjuvants Market, by Administration
8.2.4.2.3 UK Vaccine Adjuvants Market, by Application
8.2.4.3 France Vaccine Adjuvants Market
8.2.4.3.1 France Vaccine Adjuvants Market, by Type
8.2.4.3.2 France Vaccine Adjuvants Market, by Administration
8.2.4.3.3 France Vaccine Adjuvants Market, by Application
8.2.4.4 Russia Vaccine Adjuvants Market
8.2.4.4.1 Russia Vaccine Adjuvants Market, by Type
8.2.4.4.2 Russia Vaccine Adjuvants Market, by Administration
8.2.4.4.3 Russia Vaccine Adjuvants Market, by Application
8.2.4.5 Spain Vaccine Adjuvants Market
8.2.4.5.1 Spain Vaccine Adjuvants Market, by Type
8.2.4.5.2 Spain Vaccine Adjuvants Market, by Administration
8.2.4.5.3 Spain Vaccine Adjuvants Market, by Application
8.2.4.6 Italy Vaccine Adjuvants Market
8.2.4.6.1 Italy Vaccine Adjuvants Market, by Type
8.2.4.6.2 Italy Vaccine Adjuvants Market, by Administration
8.2.4.6.3 Italy Vaccine Adjuvants Market, by Application
8.2.4.7 Rest of Europe Vaccine Adjuvants Market
8.2.4.7.1 Rest of Europe Vaccine Adjuvants Market, by Type
8.2.4.7.2 Rest of Europe Vaccine Adjuvants Market, by Administration
8.2.4.7.3 Rest of Europe Vaccine Adjuvants Market, by Application
8.3 Asia Pacific Vaccine Adjuvants Market
8.3.1 Asia Pacific Vaccine Adjuvants Market, by Type
8.3.1.1 Asia Pacific Particulate Market, by Country
8.3.1.2 Asia Pacific Adjuvant Emulsion Market, by Country
8.3.1.3 Asia Pacific Pathogen Market, by Country
8.3.1.4 Asia Pacific Combination Market, by Country
8.3.1.5 Asia Pacific Others Market, by Country
8.3.2 Asia Pacific Vaccine Adjuvants Market, by Administration
8.3.2.1 Asia Pacific Intramuscular Market, by Country
8.3.2.2 Asia Pacific Intranasal Market, by Country
8.3.2.3 Asia Pacific Oral Market, by Country
8.3.2.4 Asia Pacific Intradermal Market, by Country
8.3.2.5 Asia Pacific Others Market, by Country
8.3.3 Asia Pacific Vaccine Adjuvants Market, by Application
8.3.3.1 Asia Pacific Infectious Diseases Market, by Country
8.3.3.2 Asia Pacific Cancer Market, by Country
8.3.3.3 Asia Pacific Others Market, by Country
8.3.4 Asia Pacific Vaccine Adjuvants Market, by Country
8.3.4.1 China Vaccine Adjuvants Market
8.3.4.1.1 China Vaccine Adjuvants Market, by Type
8.3.4.1.2 China Vaccine Adjuvants Market, by Administration
8.3.4.1.3 China Vaccine Adjuvants Market, by Application
8.3.4.2 Japan Vaccine Adjuvants Market
8.3.4.2.1 Japan Vaccine Adjuvants Market, by Type
8.3.4.2.2 Japan Vaccine Adjuvants Market, by Administration
8.3.4.2.3 Japan Vaccine Adjuvants Market, by Application
8.3.4.3 India Vaccine Adjuvants Market
8.3.4.3.1 India Vaccine Adjuvants Market, by Type
8.3.4.3.2 India Vaccine Adjuvants Market, by Administration
8.3.4.3.3 India Vaccine Adjuvants Market, by Application
8.3.4.4 South Korea Vaccine Adjuvants Market
8.3.4.4.1 South Korea Vaccine Adjuvants Market, by Type
8.3.4.4.2 South Korea Vaccine Adjuvants Market, by Administration
8.3.4.4.3 South Korea Vaccine Adjuvants Market, by Application
8.3.4.5 Singapore Vaccine Adjuvants Market
8.3.4.5.1 Singapore Vaccine Adjuvants Market, by Type
8.3.4.5.2 Singapore Vaccine Adjuvants Market, by Administration
8.3.4.5.3 Singapore Vaccine Adjuvants Market, by Application
8.3.4.6 Malaysia Vaccine Adjuvants Market
8.3.4.6.1 Malaysia Vaccine Adjuvants Market, by Type
8.3.4.6.2 Malaysia Vaccine Adjuvants Market, by Administration
8.3.4.6.3 Malaysia Vaccine Adjuvants Market, by Application
8.3.4.7 Rest of Asia Pacific Vaccine Adjuvants Market
8.3.4.7.1 Rest of Asia Pacific Vaccine Adjuvants Market, by Type
8.3.4.7.2 Rest of Asia Pacific Vaccine Adjuvants Market, by Administration
8.3.4.7.3 Rest of Asia Pacific Vaccine Adjuvants Market, by Application
8.4 LAMEA Vaccine Adjuvants Market
8.4.1 LAMEA Vaccine Adjuvants Market, by Type
8.4.1.1 LAMEA Particulate Market, by Country
8.4.1.2 LAMEA Adjuvant Emulsion Market, by Country
8.4.1.3 LAMEA Pathogen Market, by Country
8.4.1.4 LAMEA Combination Market, by Country
8.4.1.5 LAMEA Others Market, by Country
8.4.2 LAMEA Vaccine Adjuvants Market, by Administration
8.4.2.1 LAMEA Intramuscular Market, by Country
8.4.2.2 LAMEA Intranasal Market, by Country
8.4.2.3 LAMEA Oral Market, by Country
8.4.2.4 LAMEA Intradermal Market, by Country
8.4.2.5 LAMEA Others Market, by Country
8.4.3 LAMEA Vaccine Adjuvants Market, by Application
8.4.3.1 LAMEA Infectious Diseases Market, by Country
8.4.3.2 LAMEA Cancer Market, by Country
8.4.3.3 LAMEA Others Market, by Country
8.4.4 LAMEA Vaccine Adjuvants Market, by Country
8.4.4.1 Brazil Vaccine Adjuvants Market
8.4.4.1.1 Brazil Vaccine Adjuvants Market, by Type
8.4.4.1.2 Brazil Vaccine Adjuvants Market, by Administration
8.4.4.1.3 Brazil Vaccine Adjuvants Market, by Application
8.4.4.2 Argentina Vaccine Adjuvants Market
8.4.4.2.1 Argentina Vaccine Adjuvants Market, by Type
8.4.4.2.2 Argentina Vaccine Adjuvants Market, by Administration
8.4.4.2.3 Argentina Vaccine Adjuvants Market, by Application
8.4.4.3 UAE Vaccine Adjuvants Market
8.4.4.3.1 UAE Vaccine Adjuvants Market, by Type
8.4.4.3.2 UAE Vaccine Adjuvants Market, by Administration
8.4.4.3.3 UAE Vaccine Adjuvants Market, by Application
8.4.4.4 Saudi Arabia Vaccine Adjuvants Market
8.4.4.4.1 Saudi Arabia Vaccine Adjuvants Market, by Type
8.4.4.4.2 Saudi Arabia Vaccine Adjuvants Market, by Administration
8.4.4.4.3 Saudi Arabia Vaccine Adjuvants Market, by Application
8.4.4.5 South Africa Vaccine Adjuvants Market
8.4.4.5.1 South Africa Vaccine Adjuvants Market, by Type
8.4.4.5.2 South Africa Vaccine Adjuvants Market, by Administration
8.4.4.5.3 South Africa Vaccine Adjuvants Market, by Application
8.4.4.6 Nigeria Vaccine Adjuvants Market
8.4.4.6.1 Nigeria Vaccine Adjuvants Market, by Type
8.4.4.6.2 Nigeria Vaccine Adjuvants Market, by Administration
8.4.4.6.3 Nigeria Vaccine Adjuvants Market, by Application
8.4.4.7 Rest of LAMEA Vaccine Adjuvants Market
8.4.4.7.1 Rest of LAMEA Vaccine Adjuvants Market, by Type
8.4.4.7.2 Rest of LAMEA Vaccine Adjuvants Market, by Administration
8.4.4.7.3 Rest of LAMEA Vaccine Adjuvants Market, by Application
Chapter 9. Company Profiles
9.1 Novavax, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 SPI Pharma, Inc. (Associated British Foods PLC)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 Agenus Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 InvivoGen SAS
9.4.1 Company Overview
9.4.2 SWOT Analysis
9.5 Seppic S.A. (L’Air Liquide S.A.)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Riboxx GmbH
9.6.1 Company Overview
9.7 GlaxoSmithKline PLC (GSK)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Trials and Approvals:
9.7.6 SWOT Analysis
9.8 CSL Limited
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.6 SWOT Analysis
9.9 Croda International PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Acquisition and Mergers:
9.10. Merck & Co., Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Chapter 10. Winning Imperatives of Vaccine Adjuvants Market



List of Figures

FIG 1 Methodology for the research
FIG 2 Global Vaccine Adjuvants Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Vaccine Adjuvants Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 7 Porter’s Five Forces Analysis – Vaccine Adjuvants Market
FIG 8 Global Vaccine Adjuvants Market, share by Type, 2022
FIG 9 Global Vaccine Adjuvants Market, share by Type, 2030
FIG 10 Global Vaccine Adjuvants Market, by Type, 2019 - 2030, USD Million
FIG 11 Global Vaccine Adjuvants Market, share by Administration, 2022
FIG 12 Global Vaccine Adjuvants Market, share by Administration, 2030
FIG 13 Global Vaccine Adjuvants Market, by Administration, 2019 - 2030, USD Million
FIG 14 Global Vaccine Adjuvants Market, share by Application, 2022
FIG 15 Global Vaccine Adjuvants Market, share by Application, 2030
FIG 16 Global Vaccine Adjuvants Market, by Application, 2019 - 2030, USD Million
FIG 17 Global Vaccine Adjuvants Market, share by Region, 2022
FIG 18 Global Vaccine Adjuvants Market, share by Region, 2030
FIG 19 Global Vaccine Adjuvants Market, by Region, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Novavax, Inc.
FIG 21 SWOT Analysis: Agenus Inc.
FIG 22 SWOT Analysis: InvivoGen SAS
FIG 23 SWOT Analysis: Seppic S.A.
FIG 24 Recent strategies and developments: GlaxoSmithKline PLC
FIG 25 SWOT Analysis: GlaxoSmithKline PLC
FIG 26 SWOT Analysis: CSL Limited
FIG 27 SWOT Analysis: Merck & Co., Inc.

List of Tables

TABLE 1 Global Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 2 Global Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Vaccine Adjuvants Market
TABLE 4 Product Launches And Product Expansions– Vaccine Adjuvants Market
TABLE 5 Acquisition and Mergers– Vaccine Adjuvants Market
TABLE 6 Trials and Approvals- Vaccine Adjuvants Market
TABLE 7 Global Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 8 Global Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 9 Global Particulate Market, by Region, 2019 - 2022, USD Million
TABLE 10 Global Particulate Market, by Region, 2023 - 2030, USD Million
TABLE 11 Global Adjuvant Emulsion Market, by Region, 2019 - 2022, USD Million
TABLE 12 Global Adjuvant Emulsion Market, by Region, 2023 - 2030, USD Million
TABLE 13 Global Pathogen Market, by Region, 2019 - 2022, USD Million
TABLE 14 Global Pathogen Market, by Region, 2023 - 2030, USD Million
TABLE 15 Global Combination Market, by Region, 2019 - 2022, USD Million
TABLE 16 Global Combination Market, by Region, 2023 - 2030, USD Million
TABLE 17 Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 18 Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 19 Global Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 20 Global Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 21 Global Intramuscular Market, by Region, 2019 - 2022, USD Million
TABLE 22 Global Intramuscular Market, by Region, 2023 - 2030, USD Million
TABLE 23 Global Intranasal Market, by Region, 2019 - 2022, USD Million
TABLE 24 Global Intranasal Market, by Region, 2023 - 2030, USD Million
TABLE 25 Global Oral?Market, by Region, 2019 - 2022, USD Million
TABLE 26 Global Oral?Market, by Region, 2023 - 2030, USD Million
TABLE 27 Global Intradermal?Market, by Region, 2019 - 2022, USD Million
TABLE 28 Global Intradermal?Market, by Region, 2023 - 2030, USD Million
TABLE 29 Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 30 Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 31 Global Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 32 Global Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 33 Global Infectious Diseases Market, by Region, 2019 - 2022, USD Million
TABLE 34 Global Infectious Diseases Market, by Region, 2023 - 2030, USD Million
TABLE 35 Global Cancer Market, by Region, 2019 - 2022, USD Million
TABLE 36 Global Cancer Market, by Region, 2023 - 2030, USD Million
TABLE 37 Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 38 Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 39 Global Vaccine Adjuvants Market, by Region, 2019 - 2022, USD Million
TABLE 40 Global Vaccine Adjuvants Market, by Region, 2023 - 2030, USD Million
TABLE 41 North America Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 42 North America Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 43 North America Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 44 North America Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 45 North America Particulate Market, by Country, 2019 - 2022, USD Million
TABLE 46 North America Particulate Market, by Country, 2023 - 2030, USD Million
TABLE 47 North America Adjuvant Emulsion Market, by Country, 2019 - 2022, USD Million
TABLE 48 North America Adjuvant Emulsion Market, by Country, 2023 - 2030, USD Million
TABLE 49 North America Pathogen Market, by Country, 2019 - 2022, USD Million
TABLE 50 North America Pathogen Market, by Country, 2023 - 2030, USD Million
TABLE 51 North America Combination Market, by Country, 2019 - 2022, USD Million
TABLE 52 North America Combination Market, by Country, 2023 - 2030, USD Million
TABLE 53 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 54 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 55 North America Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 56 North America Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 57 North America Intramuscular Market, by Country, 2019 - 2022, USD Million
TABLE 58 North America Intramuscular Market, by Country, 2023 - 2030, USD Million
TABLE 59 North America Intranasal Market, by Country, 2019 - 2022, USD Million
TABLE 60 North America Intranasal Market, by Country, 2023 - 2030, USD Million
TABLE 61 North America Oral?Market, by Country, 2019 - 2022, USD Million
TABLE 62 North America Oral?Market, by Country, 2023 - 2030, USD Million
TABLE 63 North America Intradermal?Market, by Country, 2019 - 2022, USD Million
TABLE 64 North America Intradermal?Market, by Country, 2023 - 2030, USD Million
TABLE 65 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 66 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 67 North America Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 68 North America Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 69 North America Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 70 North America Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 71 North America Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 72 North America Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 73 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 74 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 75 North America Vaccine Adjuvants Market, by Country, 2019 - 2022, USD Million
TABLE 76 North America Vaccine Adjuvants Market, by Country, 2023 - 2030, USD Million
TABLE 77 US Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 78 US Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 79 US Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 80 US Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 81 US Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 82 US Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 83 US Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 84 US Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 85 Canada Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 86 Canada Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 87 Canada Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 88 Canada Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 89 Canada Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 90 Canada Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 91 Canada Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 92 Canada Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 93 Mexico Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 94 Mexico Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 95 Mexico Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 96 Mexico Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 97 Mexico Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 98 Mexico Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 99 Mexico Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 100 Mexico Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 101 Rest of North America Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 102 Rest of North America Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 103 Rest of North America Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 104 Rest of North America Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 105 Rest of North America Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 106 Rest of North America Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 107 Rest of North America Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 108 Rest of North America Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 109 Europe Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 110 Europe Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 111 Europe Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 112 Europe Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 113 Europe Particulate Market, by Country, 2019 - 2022, USD Million
TABLE 114 Europe Particulate Market, by Country, 2023 - 2030, USD Million
TABLE 115 Europe Adjuvant Emulsion Market, by Country, 2019 - 2022, USD Million
TABLE 116 Europe Adjuvant Emulsion Market, by Country, 2023 - 2030, USD Million
TABLE 117 Europe Pathogen Market, by Country, 2019 - 2022, USD Million
TABLE 118 Europe Pathogen Market, by Country, 2023 - 2030, USD Million
TABLE 119 Europe Combination Market, by Country, 2019 - 2022, USD Million
TABLE 120 Europe Combination Market, by Country, 2023 - 2030, USD Million
TABLE 121 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 122 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 123 Europe Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 124 Europe Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 125 Europe Intramuscular Market, by Country, 2019 - 2022, USD Million
TABLE 126 Europe Intramuscular Market, by Country, 2023 - 2030, USD Million
TABLE 127 Europe Intranasal Market, by Country, 2019 - 2022, USD Million
TABLE 128 Europe Intranasal Market, by Country, 2023 - 2030, USD Million
TABLE 129 Europe Oral?Market, by Country, 2019 - 2022, USD Million
TABLE 130 Europe Oral?Market, by Country, 2023 - 2030, USD Million
TABLE 131 Europe Intradermal?Market, by Country, 2019 - 2022, USD Million
TABLE 132 Europe Intradermal?Market, by Country, 2023 - 2030, USD Million
TABLE 133 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 134 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 135 Europe Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 136 Europe Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 137 Europe Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 138 Europe Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 139 Europe Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 140 Europe Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 141 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 142 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 143 Europe Vaccine Adjuvants Market, by Country, 2019 - 2022, USD Million
TABLE 144 Europe Vaccine Adjuvants Market, by Country, 2023 - 2030, USD Million
TABLE 145 Germany Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 146 Germany Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 147 Germany Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 148 Germany Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 149 Germany Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 150 Germany Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 151 Germany Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 152 Germany Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 153 UK Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 154 UK Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 155 UK Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 156 UK Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 157 UK Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 158 UK Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 159 UK Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 160 UK Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 161 France Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 162 France Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 163 France Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 164 France Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 165 France Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 166 France Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 167 France Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 168 France Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 169 Russia Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 170 Russia Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 171 Russia Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 172 Russia Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 173 Russia Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 174 Russia Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 175 Russia Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 176 Russia Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 177 Spain Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 178 Spain Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 179 Spain Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 180 Spain Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 181 Spain Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 182 Spain Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 183 Spain Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 184 Spain Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 185 Italy Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 186 Italy Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 187 Italy Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 188 Italy Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 189 Italy Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 190 Italy Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 191 Italy Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 192 Italy Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 193 Rest of Europe Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 194 Rest of Europe Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 195 Rest of Europe Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 196 Rest of Europe Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 197 Rest of Europe Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 198 Rest of Europe Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 199 Rest of Europe Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 200 Rest of Europe Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 201 Asia Pacific Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 203 Asia Pacific Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 205 Asia Pacific Particulate Market, by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Particulate Market, by Country, 2023 - 2030, USD Million
TABLE 207 Asia Pacific Adjuvant Emulsion Market, by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Adjuvant Emulsion Market, by Country, 2023 - 2030, USD Million
TABLE 209 Asia Pacific Pathogen Market, by Country, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Pathogen Market, by Country, 2023 - 2030, USD Million
TABLE 211 Asia Pacific Combination Market, by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Combination Market, by Country, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 217 Asia Pacific Intramuscular Market, by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Intramuscular Market, by Country, 2023 - 2030, USD Million
TABLE 219 Asia Pacific Intranasal Market, by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Intranasal Market, by Country, 2023 - 2030, USD Million
TABLE 221 Asia Pacific Oral?Market, by Country, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Oral?Market, by Country, 2023 - 2030, USD Million
TABLE 223 Asia Pacific Intradermal?Market, by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Intradermal?Market, by Country, 2023 - 2030, USD Million
TABLE 225 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 227 Asia Pacific Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 229 Asia Pacific Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 231 Asia Pacific Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 232 Asia Pacific Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 233 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 234 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 235 Asia Pacific Vaccine Adjuvants Market, by Country, 2019 - 2022, USD Million
TABLE 236 Asia Pacific Vaccine Adjuvants Market, by Country, 2023 - 2030, USD Million
TABLE 237 China Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 238 China Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 239 China Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 240 China Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 241 China Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 242 China Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 243 China Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 244 China Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 245 Japan Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 246 Japan Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 247 Japan Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 248 Japan Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 249 Japan Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 250 Japan Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 251 Japan Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 252 Japan Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 253 India Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 254 India Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 255 India Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 256 India Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 257 India Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 258 India Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 259 India Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 260 India Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 261 South Korea Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 262 South Korea Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 263 South Korea Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 264 South Korea Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 265 South Korea Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 266 South Korea Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 267 South Korea Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 268 South Korea Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million